← Back to Home

Home - IMMIX BIOPHARMA INC

immixbio.com 🇺🇸 EN-US

New Hope for relapsed/refractory AL Amyloidosis ASH Presentation PressRelease Corporate Presentation KOL Event to Discuss ASH 2025 NXC-201 NEXICART-2 Phase 2 Clinical Results Oral Presentation and landscape in relapsed/refractory AL Amyloidosis Hear it From the Media ASCO Post Interview: Shahzad Raza, MD (Cleveland Clinic) Memorial Sloan Kettering: Strong Results for NXC-201 at ASCO Cleveland Clinic:

Categories

Industries: healthcare
Types: corporate

Color Palette

Primary #012d47
Accent #ff751f
Background #ededed
Secondary 1 #4d4d4d
Secondary 2 #e9f5ff

Contact Information

Phone: (310) 651-8041

Full Screenshot

Home - IMMIX BIOPHARMA INC - Full Screenshot
Loading...